378
Views
14
CrossRef citations to date
0
Altmetric
Review

Personalized therapy when tackling nonalcoholic fatty liver disease: a focus on sex, genes, and drugs

, &
Pages 831-841 | Received 07 Apr 2018, Accepted 20 Jun 2018, Published online: 03 Jul 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Paul Horn & Phlip N. Newsome. (2020) Emerging therapeutic targets for NASH: key innovations at the preclinical level. Expert Opinion on Therapeutic Targets 24:3, pages 175-186.
Read now

Articles from other publishers (13)

Alan L. Hutchison, Federica Tavaglione, Stefano Romeo & Michael Charlton. (2023) Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance. Journal of Hepatology 79:6, pages 1524-1541.
Crossref
Lin Yang, Yafei Zhu, Lu Zhou, Huimei Yin, Yan Lin & Guangsheng Wu. (2022) Transient Elastography in the Diagnosis of Pediatric Non-alcoholic Fatty Liver Disease and Its Subtypes. Frontiers in Pediatrics 10.
Crossref
José F. Català-Senent, Marta R. Hidalgo, Marina Berenguer, Gopanandan Parthasarathy, Harmeet Malhi, Pablo Malmierca-Merlo, María de la Iglesia-Vayá & Francisco García-García. (2021) Hepatic steatosis and steatohepatitis: a functional meta-analysis of sex-based differences in transcriptomic studies. Biology of Sex Differences 12:1.
Crossref
Philippe Lefebvre & Bart Staels. (2021) Hepatic sexual dimorphism — implications for non-alcoholic fatty liver disease. Nature Reviews Endocrinology 17:11, pages 662-670.
Crossref
Urša Kovač, Zala Žužek, Lucija Raspor Dall’Olio, Katka Pohar, Alojz Ihan, Miha Moškon, Damjana Rozman & Marjanca Starčič Erjavec. (2021) Escherichia coli Affects Expression of Circadian Clock Genes in Human Hepatoma Cells. Microorganisms 9:4, pages 869.
Crossref
Eva Kočar, Tadeja Režen & Damjana Rozman. (2021) Cholesterol, lipoproteins, and COVID-19: Basic concepts and clinical applications. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1866:2, pages 158849.
Crossref
Erica Jennison & Christopher D. Byrne. (2021) The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease. Clinical and Molecular Hepatology 27:1, pages 22-43.
Crossref
Yu-Cheng Lin, Chi-Chien Wu & Yen-Hsuan Ni. (2020) New Perspectives on Genetic Prediction for Pediatric Metabolic Associated Fatty Liver Disease. Frontiers in Pediatrics 8.
Crossref
Carolyn M. Klinge. (2020) Estrogenic control of mitochondrial function. Redox Biology 31, pages 101435.
Crossref
Ali Zarrinpar, Un Bi Kim & Vijay Boominathan. (2020) Phenotypic Response and Personalized Medicine in Liver Cancer and Transplantation: Approaches to Complex Systems. Advanced Therapeutics 3:4, pages 1900167.
Crossref
Antoni Sicras-Mainar, Rocío Aller, Javier Crespo Garcia, José Luis Calleja, Juan Turnes, Manuel Romero-Gómez & Salvador Augustín. (2020) Overall clinical and economic impact of non-alcoholic fatty liver disease. Revista Española de Enfermedades Digestivas.
Crossref
Urša Kovač, Cene Skubic, Laura Bohinc, Damjana Rozman & Tadeja Režen. (2019) Oxysterols and Gastrointestinal Cancers Around the Clock. Frontiers in Endocrinology 10.
Crossref
Zhengli Tang, Minh Pham, Yiming Hao, Fang Wang, Devashru Patel, Lori Jean-Baptiste, Lin Fan, Weijian Wang, Yiqin Wang & Feng Cheng. (2019) Sex, Age, and BMI Modulate the Association of Physical Examinations and Blood Biochemistry Parameters and NAFLD: A Retrospective Study on 1994 Cases Observed at Shuguang Hospital, China. BioMed Research International 2019, pages 1-7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.